Efficacy and safety of pegylated recombinant human granulocyte colony-stimulating factor in the prevention of chemotherapy-induced neutropenia in patients with breast cancer.

被引：0
|
作者：
Chong, Xiaoyu
Zhu, Xiaoli
Li, Xuejuan
Gao, Lingna
Ma, Hongfang
Chong, Baogui
机构：
[1] Hengshui Peoples Hosp, Hengshui, Peoples R China
[2] CSPC Baike Shandong Biopharmaceut Co Ltd, Shijiazhuang, Hebei, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e12515
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Granulocyte colony-stimulating factor for chemotherapy-induced neutropenia in patients with small cell lung cancer - The 40% rule revisited
    Calhoun, EA
    Schumock, GT
    McKoy, JM
    Pickard, S
    Fitzner, KA
    Heckinger, EA
    Powell, EF
    McCaffrey, KR
    Bennett, CL
    PHARMACOECONOMICS, 2005, 23 (08) : 767 - 775
  • [22] Effect of recombinant human granulocyte colony stimulating factor (lenograstim) on chemotherapy induced neutropenia in patients with urothelial cancer
    Kotake, T
    Usami, M
    Miki, T
    Togashi, M
    Akaza, H
    Kubota, Y
    Matsumura, Y
    INTERNATIONAL JOURNAL OF UROLOGY, 1999, 6 (02) : 61 - 67
  • [23] Efficacy, effectiveness and safety of long-acting granulocyte colony-stimulating factors for prophylaxis of chemotherapy-induced neutropenia in patients with cancer: a systematic review
    Alena M. Pfeil
    Kim Allcott
    Ruth Pettengell
    Gunter von Minckwitz
    Matthias Schwenkglenks
    Zsolt Szabo
    Supportive Care in Cancer, 2015, 23 : 525 - 545
  • [24] Efficacy, effectiveness and safety of long-acting granulocyte colony-stimulating factors for prophylaxis of chemotherapy-induced neutropenia in patients with cancer: a systematic review
    Pfeil, Alena M.
    Allcott, Kim
    Pettengell, Ruth
    von Minckwitz, Gunter
    Schwenkglenks, Matthias
    Szabo, Zsolt
    SUPPORTIVE CARE IN CANCER, 2015, 23 (02) : 525 - 545
  • [25] Efficacy of recombinant human granulocyte colony-stimulating factor and recombinant human granulocyte macrophage colony-stimulating factor in neutropenic children with malignancies
    Lydaki, E
    Bolonaki, E
    Stiakaki, E
    Dimitriou, H
    Kambourakis, A
    Kalmantis, T
    Kalmanti, M
    BLOOD, 1995, 86 (10) : 2785 - 2785
  • [26] Exploring optimal administration timing of pegylated recombinant human granulocyte colony-stimulating factor for chemotherapy-induced neutropenia in early breast cancer treated with pharmorubicin and endoxan: a prospective randomized controlled clinical trial
    Xu, Yinggang
    Huang, Lifeng
    Wang, Jue
    He, Jinzhi
    Wang, Ye
    Zhang, Weiwei
    Chen, Rui
    Huang, Xiaofeng
    Liu, Jin
    Wan, Xinyu
    Shi, Wenjie
    Xu, Lu
    Zha, Xiaoming
    BMC CANCER, 2024, 24 (01)
  • [27] Safety and efficacy study of the recombinant granulocyte colony-stimulating factor for prevention of neutropenia and neutropenia-related complications in women with metastatic breast cancer receiving docetaxel/doxorubicin
    Liutkauskiene, Sigita
    Sveikata, Audrius
    Juozaityte, Elona
    Characiejus, Dainius
    Juodzbaliene, Edita
    Kregzdyte, Rima
    Fokas, Vidmantas
    MEDICINA-LITHUANIA, 2009, 45 (08): : 600 - 606
  • [28] Anaphylaxis caused by pegylated recombinant human granulocyte colony-stimulating factor
    Chen, Chen
    Qi, Jian
    Wang, Juandong
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2023, 29 (03) : 727 - 730
  • [29] Treatment of autoimmune neutropenia with recombinant human granulocyte colony-stimulating factor
    Carulli, G
    ANNALS OF HEMATOLOGY, 1998, 76 (02) : 93 - 94
  • [30] HUMAN RECOMBINANT GRANULOCYTE COLONY-STIMULATING FACTOR FOR THE TREATMENT OF AUTOIMMUNE NEUTROPENIA
    TAKAHASHI, K
    TANIGUCHI, S
    AKASHI, K
    FUJIMOTO, K
    SIBUYA, T
    ISHIBASHI, H
    HARADA, M
    NIHO, Y
    ACTA HAEMATOLOGICA, 1991, 86 (02) : 95 - 98
12345